GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹45 Cr | ₹40 Cr | ₹30 Cr | ₹24 Cr | ₹19 Cr |
What is the latest Total Current Liabilities ratio of GENNEX LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹45 Cr |
| Mar2024 | ₹40 Cr |
| Mar2023 | ₹30 Cr |
| Mar2022 | ₹24 Cr |
| Mar2021 | ₹19 Cr |
How is Total Current Liabilities of GENNEX LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹45 Cr | 10.54 | |
| Mar2024 | ₹40 Cr | 36.57 | |
| Mar2023 | ₹30 Cr | 21.91 | |
| Mar2022 | ₹24 Cr | 27.25 | |
| Mar2021 | ₹19 Cr | - | |
Compare Total Current Liabilities of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹253.7 Cr | 4% | 14.4% | -18.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,667.0 Cr | 1.4% | -4.5% | 6.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,805.0 Cr | 0.1% | -2.5% | -0.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,554.0 Cr | -2.7% | 1.2% | 39.3% | Stock Analytics | |
| CIPLA | ₹109,120.0 Cr | -2.3% | -5.3% | -9.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,920.0 Cr | -0.5% | -4.7% | -5.4% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | 4% |
14.4% |
-18.4% |
| SENSEX | 4.3% |
2.6% |
-6.4% |
You may also like the below Video Courses